• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home Events Elimination of Perinatal HBV and HCV Transmission: New Opportunities to Screening, Prevention, and Care

Elimination of Perinatal HBV and HCV Transmission: New Opportunities to Screening, Prevention, and Care

October 14, 2021

The United States National Institutes of Health (NIH) is committed to setting research priorities that advance progress toward viral hepatitis elimination. In 2020, Dr. Harvey Alter, NIH researcher, was awarded the Nobel Prize in Medicine and Physiology for his contributions to the discovery of HCV, exemplifying the importance of NIH to hepatitis elimination efforts.

NIH and the Coalition for Global Hepatitis Elimination (CGHE) are launching a new webinar series, “Moving from Hepatitis Discovery to Elimination” to highlight ongoing research that can benefit elimination efforts, support translation of research into implementation, and identify additional research needs.

When: October 14, 2021, 3-5pm ET

Where: Virtual

How to Attend: Click here to register for the webinar.

 

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2025 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.